Author: Stan

RNS Number : 7879L Loungers PLC 04 May 2020   For immediate release Loungers plc  (“Loungers” or the “Company”)   Issue of Equity and Total Voting Rights   Loungers announces that it has allotted and issued 650,000 ordinary shares of 1 pence each in the Company (“Ordinary Shares”) following the vesting of awards made to...

RNS Number : 7871L Tribal Group PLC 04 May 2020   TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i   1a. Identity of the issuer or the underlying issuer of existing shares to...

RNS Number : 7378L Open Orphan PLC 04 May 2020   4 May 2020   Open Orphan plc (“Open Orphan” or the “Company”) Major New Contract and Directorate Change New contract signed with US Biotechnology Company for respiratory syncytial virus (RSV) human challenge study Open Orphan plc (ORPH) the rapidly growing specialist CRO pharmaceutical services...

RNS Number : 7382L Tracsis PLC 04 May 2020     Tracsis plc   (“Tracsis” or the “Company”)   Issue of Equity   The Company confirms that following the receipt of a notice of exercise of employee options, it has today issued 33,247 ordinary shares of 0.4p each (“Ordinary Shares”) (the “New Ordinary Shares”).  ...

RNS Number : 7384L Destiny Pharma PLC 04 May 2020     Destiny Pharma plc (“Destiny Pharma” or the “Company”)   Independent expert review of data supports the potential of XF-73 to address antimicrobial resistance   Publication in peer-reviewed journal ‘suggests that Staphylococcus aureus, including MRSA, has low potential to evolve resistance to XF-73 relative...

RNS Number : 7388L Science Group PLC 04 May 2020       4 May 2020    Ventilator Programme, Trading and Financial Update   As announced on 31 March 2020, Science Group’s product development business, Sagentia, has been engaged on the UK Government’s Rapidly Manufactured Ventilator System (RMVS) initiative. The initial requirements in the “new-design”...

RNS Number : 7397L ValiRx PLC 04 May 2020       VALIRX PLC (“ValiRx”, the “Company” or the “Group”) Conditional Fundraise of £1.2 million   London, UK., 4 May 2020: ValiRx Plc (AIM: VAL), the clinical stage biotechnology company announces a conditional fundraise (the “Fundraise“) through the conditional issue of 18,069,467 new ordinary shares...

RNS Number : 7403L Iofina PLC 04 May 2020     4 May 2020   Iofina Plc (“Iofina”, the ‘Group” or the “Company”) (LSE AIM: IOF)   IO#8 Brine Supply Update     Iofina plc, specialists in the exploration and production of iodine and manufacturers of specialty chemical products, today updates the market on brine...

RNS Number : 7415L Bidstack Group PLC 04 May 2020   4 May 2020   Certain information contained within this Announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 (“MAR”). Upon publication of this Announcement, this information is now considered to be in the...

RNS Number : 7419L Zambeef Products PLC 04 May 2020     4 May 2020 Zambeef Products plc (“Zambeef” or the “Group”)   Trading Update Zambeef (AIM: ZAM), the fully integrated cold chain foods and retail business with operations in Zambia, Nigeria and Ghana, is pleased to provide the following update on trading.   The...